Français Register Login

  • All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 261/18 - Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Patent holdings for IPC class C07D 261/18

Total number of patents in this class: 320

10-year publication summary

26
36
33
20
27
28
21
11
21
5
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Theravance Biopharma R&D IP, LLC
460
48
Proteostasis Therapeutics, Inc.
70
9
F. Hoffmann-La Roche AG
7934
8
Sumitomo Chemical Company, Limited
9031
7
The Board of Trustees of the University of Illinois
2685
7
Denali Therapeutics Inc.
243
7
The Provost, Fellows, Foundation Scholars, and The Other Members of Board, of The College of The Holy and Undivided Trinity of Queen Elizabeth, Near Dublin
163
7
The University of Queensland
658
7
Boehringer Ingelheim International GmbH
4697
6
VALO Health, Inc.
172
6
Hoffmann-La Roche Inc.
3404
5
Cornell University
3292
5
Shionogi & Co., Ltd.
860
5
Bristol-myers Squibb Company
4879
4
Board of Regents, The University of Texas System
5763
4
Astellas Pharma Inc.
1088
4
Epizyme, Inc.
370
4
Theravance, Inc.
66
4
The United States of America, as represented by the Secretary, Department of Health and Human Services
2842
4
Vanderbilt University
1894
4
Other owners 165

  • ipowner home
  • ipqwery home
  • contact us
  • privacy policy
  • terms and conditions
© 2025 IPQwery All rights reserved